| | | | | | | | | | |
|
| |
|
| Dockets
Entered On January 23, 2004
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1977P-0353
|
| HAIR DYE PROD CONTAINING 4-DIAMINOANISOLE OR 4-DIAMIN-SUL
|
|
|
|
|
| 1995S-0316
|
| 75-Day Premarket Notifications for New Dietary Ingredients
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| 2000P-1211
|
| Establish Mandatory Pre-Market Safety Testing for GE Foods
|
|
|
|
|
| 2003D-0478
|
| Guidance on Marketed Unapproved Drugs Compliance Policy Guide
|
|
|
|
|
| 2003D-0497
|
| Guidance for Industry on Pharmacogenomic Data Submissions
|
|
|
|
|
| 2003N-0344
|
| Consumer-Directed Promotion; Public Meeting
|
|
|
|
|
| 2003N-0400
|
| Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals
|
|
|
|
|
| 2003N-0496
|
| Food Labeling: Health Claims; Dietary Guidance
|
|
|
|
|
| 2003N-0502
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Study to Measure the Compliance of Prescribers with the Contraindication of the Use of b Triptansb in Migraine Headac
|
|
|
|
|
|
| 2003P-0362
|
| Over-the-counter Hearing Aids
|
|
|
|
|
| 2004P-0006
|
| Stay approval of abbbreviated new drug applications for controlled release oxycodone hydrochloride products that list OxyContin oxycodone HCI controlled-release
|
|
| |
|
| 1977P-0353
|
| HAIR DYE PROD CONTAINING 4-DIAMINOANISOLE OR 4-DIAMIN-SUL
|
|
|
| ACK 2
|
| HFA-305 to Cosmetic, Toiletry & Fragrance Assn.
|
| Vol #:
|
| 5
|
|
|
|
|
| CP 2
|
| Cosmetic, Toiletry & Fragrance Assn
|
| Vol #:
|
| 5
|
|
|
|
|
| 1995S-0316
|
| 75-Day Premarket Notifications for New Dietary Ingredients
|
|
|
|
|
| SUP
14
|
| Sidley Austin Brown & Wood
|
| Vol #:
|
| 119
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| LET
12328
|
| Food Science Corporation
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12329
|
| FoodScience Corporation
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12330
|
| Food Science Corporation
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12331
|
| FoodScience Corporation
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12332
|
| FoodScience Corporation
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12333
|
| FoodScience Corporation
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12334
|
| FoodScience Corporation
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12335
|
| PhytoPharmica Natural Medicines
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12336
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12337
|
| PhytoPharmica Natural Medicines
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12338
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12339
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12340
|
| Enzymatic Natural Medicines
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12341
|
| PhytoPharmica Natural Medicines
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12342
|
| Enzymatic Therapy Natural Medcines
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12343
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 99
|
|
| | | | | | | | |
|
|
|
|
| LET
12344
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12345
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12346
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12347
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12348
|
| PhytoPharmica Natural Medicines
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12349
|
| PhytoPharmica Natural Medicines
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12350
|
| Intetrative Therapeutics Inc.
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12351
|
| Integrative Therapeutics Inc.
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12352
|
| Integrative Therapeutics Inc.
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12353
|
| Integrative Therapeutics Inc.
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12354
|
| Integrative Therapeutics Inc.
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12355
|
| Integrative Therapeutics Inc.
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12356
|
| PhytoPharmica Natural Medicines
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12357
|
| Integrative Therapeutics Inc.
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12358
|
| Integrative Therapeutics Inc.
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12359
|
| Integrative Therapeutics Inc.
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12360
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12361
|
| Enzymatic Therapy natural Medicines
|
| Vol #:
|
| 99
|
|
|
|
|
| LET
12362
|
| Palm Institute
|
| Vol #:
|
| 99
|
|
| |
|
| 2000P-1211
|
| Establish Mandatory Pre-Market Safety Testing for GE Foods
|
|
|
|
|
| EMC 5744
|
| Sandra Pierzinski
|
| Vol #:
|
| 789
|
|
|
|
|
| EMC 5745
|
| Sandra Pierzinski
|
| Vol #:
|
| 789
|
|
|
|
|
| EMC 5746
|
| Janie Desimone
|
| Vol #:
|
| 789
|
|
|
|
|
| EMC 5747
|
| Carla Buhler
|
| Vol #:
|
| 789
|
|
|
|
|
| EMC 5748
|
| Billie Morelli
|
| Vol #:
|
| 789
|
|
|
|
|
| EMC 5749
|
| Pamela Schneider
|
| Vol #:
|
| 789
|
|
|
|
|
| EMC 5750
|
| Barry Brown
|
| Vol #:
|
| 789
|
|
|
|
|
| EMC 5751
|
| Keiht Copenhagen
|
| Vol #:
|
| 789
|
|
|
|
|
| EMC 5752
|
| Barbara Centofante
|
| Vol #:
|
| 789
|
|
|
|
|
| EMC 5753
|
| Sandra Trinidad
|
| Vol #:
|
| 789
|
|
|
|
|
| EMC 5754
|
| Melisse Gamache
|
| Vol #:
|
| 789
|
|
|
|
|
| EMC 5755
|
| Melisse Gamache
|
| Vol #:
|
| 789
|
|
|
|
|
| 2003D-0478
|
| Guidance on Marketed Unapproved Drugs Compliance Policy Guide
|
|
|
|
|
| C
64
|
| Morgan Lewis & Bockius, LLP
|
| Vol #:
|
| 5
|
|
|
|
|
| 2003D-0497
|
| Guidance for Industry on Pharmacogenomic Data Submissions
|
|
| | | | | | | | |
|
| |
|
| C
2
|
| Perlegen Sciences
|
| Vol #:
|
| 1
|
|
|
|
|
| C
3
|
| Genzyme Corporation (Genzyme)
|
| Vol #:
|
| 1
|
|
|
|
|
| C
4
|
| Johnson & Johnson Pharmaceutical Research (Johnson & Johnson)
|
| Vol #:
|
| 1
|
|
|
|
|
| C
5
|
| Affymetrix
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003N-0344
|
| Consumer-Directed Promotion; Public Meeting
|
|
|
|
|
| C
4
|
| Coalition for Healthcare Communication
|
| Vol #:
|
| 3
|
|
|
|
|
| 2003N-0400
|
| Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals
|
|
|
|
|
| C
46
|
| People for the Ethical Treatment of Animals (PETA)
|
| Vol #:
|
| 5
|
|
|
|
|
| C 47
|
| R. R. Beair
|
| Vol #:
|
| 5
|
|
|
|
|
| C 48
|
| J. Taylor
|
| Vol #:
|
| 5
|
|
|
|
|
| C 49
|
| R. Burnett
|
| Vol #:
|
| 5
|
|
|
|
|
| C 50
|
| No signature
|
| Vol #:
|
| 5
|
|
|
|
|
| C 51
|
| M. Cline
|
| Vol #:
|
| 5
|
|
|
|
|
| C 52
|
| 52 signatures
|
| Vol #:
|
| 5
|
|
|
|
|
| C 53
|
| A. Jung
|
| Vol #:
|
| 5
|
|
|
|
|
| C
54
|
| Millermeade Farms
|
| Vol #:
|
| 1
|
|
|
|
|
| C 55
|
| 396 signatures
|
| Vol #:
|
| 5
|
|
|
|
|
| C
56
|
| Columbus Zoo
|
| Vol #:
|
| 5
|
|
|
|
|
| C 57
|
| M. Mori, DVM
|
| Vol #:
|
| 5
|
|
|
|
|
| C
58
|
| Wild Time Zoological Center
|
| Vol #:
|
| 5
|
|
|
|
|
| C
59
|
| American Zoo and Aquarium Assn (AZA)
|
| Vol #:
|
| 5
|
|
|
|
|
| C 60
|
| No signature
|
| Vol #:
|
| 5
|
|
|
|
|
| C
61
|
| Animal Protection Institute (API)
|
| Vol #:
|
| 5
|
|
|
|
|
| C 62
|
| No signature
|
| Vol #:
|
| 5
|
|
|
|
|
| C 63
|
| No signature
|
| Vol #:
|
| 8
|
|
|
|
|
| 2003N-0496
|
| Food Labeling: Health Claims; Dietary Guidance
|
|
|
|
|
| C
1
|
| HFW-1 to Honorable Ron Paul
|
| Vol #:
|
| 1
|
|
|
|
|
| C
2
|
| HFW-1 to Honorable Frank Pallone, Jr.
|
| Vol #:
|
| 1
|
|
|
|
|
| C
3
|
| HFW-1 to Honorable Edward M. Kennedy
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003N-0502
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Study to Measure the Compliance of Prescribers with the Contraindication of the Use of b Triptansb in Migraine Headac
|
|
|
|
|
|
|
|
|
|
|
| C
1
|
| GlaxoSmithKline
|
| Vol #:
|
| 1
|
|
|
|
|
| C
2
|
| American Heachache Society
|
| Vol #:
|
| 1
|
|
|
|
|
| C
3
|
| Pfizer Pharmaceuticals Group (Pfizer)
|
| Vol #:
|
| 1
|
|
